Walleye Trading
PCRX icon

Walleye Trading’s Pacira BioSciences PCRX Stock Holding History

Walleye Trading’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,873
Closed -$1.03M – 4470
2024
Q2 		$1.03M Buy
35,873
+14,006
+64% +$399K ﹤0.01% 2049
2024
Q1 		$639K Buy
+21,867
New +$672K ﹤0.01% 2604
2023
Q4 		– Sell
-222
Closed -$6.5K – 5385
2023
Q3 		$6.81K Buy
+222
New +$8K ﹤0.01% 4581
2023
Q1 		– Sell
-7,001
Closed -$270K – 5246
2022
Q4 		$270K Sell
7,001
-1,196
-15% -$58.2K ﹤0.01% 3337
2022
Q3 		$436K Buy
8,197
+1,681
+26% +$93.5K ﹤0.01% 3028
2022
Q2 		$380K Sell
6,516
-1,312
-17% -$85.9K ﹤0.01% 3165
2022
Q1 		$597K Buy
7,828
+3,067
+64% +$204K ﹤0.01% 2722
2021
Q4 		$286K Buy
+4,761
New +$263K ﹤0.01% 3520
2021
Q3 		– Sell
-4,531
Closed -$275K – 5581
2021
Q2 		$275K Buy
+4,531
New +$287K ﹤0.01% 3590
2019
Q3 		– Sell
-1,136
Closed -$49K – 4332
2019
Q2 		$49K Buy
+1,136
New +$48.2K ﹤0.01% 3547
2017
Q3 		– Sell
-1
Closed – – 4482
2017
Q2 		$0 Buy
+1
New +$46 ﹤0.01% 4833
2017
Q1 		– Sell
-31,077
Closed -$1.34M – 5049
2016
Q4 		$1M Buy
31,077
+30,576
+6,103% +$1.02M 0.01% 1510
2016
Q3 		$17K Buy
+501
New +$19.6K ﹤0.01% 4245
2016
Q1 		– Sell
-1,100
Closed -$84K – 5711
2015
Q4 		$84K Buy
+1,100
New +$62.3K ﹤0.01% 3441

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Walleye Trading's PCRX Position: Q3 2024 in Review

Walleye Trading sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 35,873 shares — an estimated $1.03M sold.

Walleye Trading first reported a position in PCRX in Q4 2015 and held it in 14 quarters. The position peaked at $1.03M in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Walleye Trading reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Walleye Trading sold 35,873 Pacira BioSciences shares in Q3 2024, an estimated $1.03M.
  • Walleye Trading first reported a position in Pacira BioSciences in Q4 2015 and held it in 14 quarters.
  • Walleye Trading's Pacira BioSciences position peaked at $1.03M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.